Benjamin Young, M.D., Ph.D.
Dr. Young is the Chief Medical Officer of the International Association of Providers of AIDS Care (IAPAC), one of the world's largest organizations of HIV health care providers. He is also an adjunct professor at the Korbel School of International Studies at the University of Denver and an assistant clinical professor of medicine at the University of Colorado. Dr. Young provides care for people living with HIV at APEX Family Medicine in Denver.
The much-traveled Dr. Young is a long-term resident of Colorado's Rocky Mountains, but was raised in New York and San Diego. Dr. Young began his graduate studies at the University of Colorado in Boulder, where he received a Ph.D. in molecular biology and biochemistry working in the laboratory of Nobel laureate Thomas Cech. He went on to earn his medical doctorate in 1992 from the University of Colorado School of Medicine and completed his post-graduate training in internal medicine and infectious diseases at the University of Colorado.
Dr. Young is the author of more than 60 journal articles, reviews and book chapters relating to HIV and its treatment. He is a principal investigator with the U.S. Centers for Disease Control and Prevention's HIV Outpatient Study (HOPS), a massive ongoing analysis of the health of HIV-positive people throughout the U.S. A member of the HIV Medicine Association, the International AIDS Society and the American Academy of HIV Medicine, Dr. Young is also actively involved in educating health care professionals and community groups throughout the world on HIV-related subjects. He has devoted the past six years to training HIV physicians in Eastern Europe and Central Asia, where he witnessed a coup d'etat and a polio epidemic.
Dr. Young has received consulting or speaking fees from Bristol-Myers Squibb, Cerner Corporation, Gilead Sciences, GlaxoSmithKline, Merck & Co., Monogram Biosciences and ViiV Healthcare. He has received research funding from Bristol-Myers Squibb Company, Cerner Corporation, Gilead Sciences, GlaxoSmithKline, Merck & Co., and ViiV Healthcare. (Disclosures were last updated April 2013.)